Experimental Study of Fibrinolytic Factors and Its Inhibitors in Rabbits’ Tissues Extract.

Xiaohua Xu(Chinese PLA General Hospital), Xiaoying Zhao(Handan College), Gen-bo Xu(Second Affiliated Hospital of Zhejiang University), Xingguo Lu(Second Affiliated Hospital of Zhejiang University), Liansheng Huang(Second Affiliated Hospital of Zhejiang University)
Blood
November 16, 2004
10.1182/blood.v104.11.3965.3965
Cited by 0

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2013|247
Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis
|BMC Cancer|2014|146
Systemic Lupus Erythematous and Malignancy Risk: A Meta-Analysis
|PLoS ONE|2015|115